chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid RNA Test Positive; This is a spontaneous report from a contactable consumer or other non hcp (Patient herself). A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EM6201, Expiration date: Unknown) via an unspecified route of administration in the left arm on 15Feb2021 as SINGLE DOSE for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced covid RNA test positive on 18Feb2021. The patient stated she received the first dose last Monday, but was then diagnosed with covid on Thursday. She didn't realize she was coming down with it when getting vaccine. Her second dose is scheduled on 08Mar2021. Her First Dose was on 15Feb2021. Then on 18Feb2021 she was diagnosed positive with covid. They did a covid RNA Test, which consisted of doing a nasal swab, her result was positive. She did not express any symptoms before the first dose. She has had no positive covid test before the first dose. She took the actual covid test on thursday 18Feb2021 and got the result on Friday the next day. The patient decided to get tested because after the first dose on the 15th, she noticed on Wednesday afternoon she started to have symptoms, she was experiencing aches, fever, chills. The only things ongoing at the moment are congestion and body aches and being tired. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on 18Feb2021. The outcome of event was unknown.
Patient states she experienced high fever and vomiting. She was hospitalized and the physician also noted she had high liver enzymes which have since resolved and gone back to being within normal limits. Her symptom onset was within 24 hours of the immunization.
Information has been received from a physician concerning a 16 year old female patient who on 20-JUL-2009 and 16-NOV-2010 was vaccinated with a first and second dose of GARDASIL respectively (lot # not provided). Physician reported that in 1993 and 1994, the patient finished the series of measles-mumps-rubella vaccine, HIB conj-hepatitis B vaccine, poliovirus vaccine and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, and on 27-JAN-2010 the patient experienced shingles. The patient sought medical attention at the office visit. On unspecified date, the patient recovered from shingles. No further information is available.
Bilious vomiting X 5 in 1 1/2 hours after vaccination. Lethargy, paleness that lasted a few hours.
pt recvd vax 20APR94 & phone call from mom 22APR94 t102 R & blister like formation on rt leg, took pt to MD who said only local react; phone call to mom 25APR93; no fever & areas looks fine, no fever;
This spontaneous report as received from a registered nurse refers to unknown patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with an improperly stored doses of M-M-R II (Lot # L049316, expiration date 03-DEC-2017; M006544, expiration date 03-FEB-2016) (Dose and route were not provided). Concomitant medications were not reported. The temperature excursion details were 9 degree C for 1 hour 24 minutes, with an additional excursion of 10 degree C for 2 hours for M-M-R II Lot # L049316, expiration date 03-DEC-2017. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
It came on very gradual, but I had a cough that continued to get worse. I was avoiding cold liquids and was living on cough drops. I contacted my doctor, and they thought it might have been brought on by acid reflux. They suggested Omeprazole and Chlorpheniramine Maleate. I also take Fluticasone. It has gotten a lot better.
Fever, chills, nausea, head ache, sore arm.  Took advil
Did NOT occur until 1 week AFTER injection: pain, tenderness, swelling in upper arm & pain, hardness and redness; these were preceded by diarrhea and fatigue.  Better in 2/3 days.
Hearing loss; ringing in the ears; Severe insomnia; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported for herself that:  A female of unspecified age received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via unspecified route of administration on unspecified date as dose 2, single for covid 19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported) via unspecified route of administration as dose 1, single for covid 19 immunization. Patient had no other health issues. It is not related to a study or programme. Patient reported that since her second dose of the Pfizer Covid 19 Vaccine she had experienced severe insomnia, hearing loss and ringing in the ears. Reporter seriousness for events were unspecified. Investigation not reported. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
"3 cm circle of erythema on right side of (L) thigh. A bit of induration, but no underlying mass and no warmth." This is MD's report. Also says "local reaction, will do VAERS report, may have all theses vaccines again." Patient seen for doctor visit. No treatment.
Patient developed local redness, swelling, and itching within 30 minutes of injection. About 2 hours later, pt developed throat swelling and shortness of breath.
legs and feet hurt; multiple falls; decreased appetite; also nausea; body ache; gait problem; extreme fatigue; shaky feet; dizziness; joint pain; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose of shingrix on an unknown date).   On 14th November 2020, the patient received the 2nd dose of Shingrix. In November 2020, 1 week after receiving Shingrix, the patient experienced fatigue, tremor limb, dizziness, joint pain, general body pain, gait disorder and nausea. On an unknown date, the patient experienced leg pain, fall and decreased appetite. On an unknown date, the outcome of the fatigue, tremor limb, dizziness, joint pain, leg pain, general body pain, gait disorder, fall, nausea and decreased appetite were unknown.   It was unknown if the reporter considered the fatigue, tremor limb, dizziness, joint pain, leg pain, general body pain, gait disorder, fall, nausea and decreased appetite to be related to Shingrix.  Additional details were provided as follows: The case was reported by the daughter for her mother. About a week after receiving dose of Shingrix, patient experienced extreme fatigue, shaky feet, dizziness, joint pain, body aches, leg pain, multiple falls, nausea and gait disorder and decreased appetite. The patient consented to follow up.
Patient reported Grade 3 arm pain lasting for approximately 1 month post vaccination. She described that she could not raise her arm up to comb her hair or over her head. The pain was severe and she needed assistance for activities of daily living. She did not report this to her medical provider and did not seek medical treatment. She described that it was worse in the morning and lessened by evening.  It is resolved for the most part as of today. She still has some pain when she raises it above her head but it is much less than her initial pain following the injection.
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (lot #, expiration date, dose and route were unknown). On an unknown date after the patient received PNEUMOVAX 23, the patient stated that the injection site was red, very swollen and hard. The outcome of the events was reported as not recovered. The causality was not provided. Additional information has been requested.
This case was reported by a nurse and described the occurrence of erythema multiforme in a 21 month old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject had no pre-existing medical conditions. On 10/26/05, the subject received second dose of Infanrix in the right hip (lot AC14A006AA). On 10/26/05, the subject was also vaccinated with Haemophilus influenzae type B conjugate vaccine and 7-valent pneumococcal conjugate vaccine. On 10/31/05, 5 days after vaccination with Infanrix, the subject experienced irregular round erythematous blanchable lesions located around the indurated area of the injection site of Infanrix. The subject was seen at a physician's office on 11/1/05 and was diagnosed with erythema multiforme. The nurse reported that the erythema multiforme was limited to the area around the site of injection. The vaccination course with Infanrix was discontinued. The outcome of the erythema multiforme was not provided. The nurse considered the events to probably be related to vaccination with Infanrix. Comment: Erythema multiforme was assessed as medically serious (OMIC).
allergic reaction; Whole body was itching; Spot where the vaccine was administered turned into a lump; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 15:45 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID), amlodipine besilate (NORVASC), simvastatin (MANUFACTURER UNKNOWN) and ramipril (ALTACE); all for unknown indication from an unknown date . Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021, after the vaccine was administered, the patient felt whole body was itching, as if patient had allergic reaction. That lasted till the day after the vaccine. Then on an unknown date in 2021, the spot where the vaccine was administered turned into a lump, which was present even after 2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events  itching and  allergic reaction was recovered on 25Mar2021; while that of the event vaccination site mass was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
PT. reported tongue numbness, throat thickening 10 minutes after vaccine was administered.  Pt was was monitored for an additional 20 minutes in EMT triage room. Pt. reported feeling better at 1325. Vitals BP: 189/88, BP 64, Respiratory 99. After monitoring BP: 162/76, Pulse: 68, Respiratory: 99
Patient picked at the immunization site and scratched until a cellulitis developed on that site.  The hospitalization below was to treat not only the cellulitis that developed but rule out further infection and osteomyelitis in the pre-existing hip cellulitis.
I was extremely fatigued the next day, April 1st, after my vaccine. I went to work but had to leave after lunch because I was so exhausted. I rested the entire rest of the day. I had a low grade fever of 100.9. On April 2nd, I felt much better and was able to carryon with my regular activities.
lt upper arm swollen, erythemic & indurated was warm to touch;affected area4/4"- 5 7/8"
Expired dose was administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 32-year-old patient who received HAV (Havrix) (batch number G99R4, expiry date 20th May 2022) for prophylaxis.   On 13th June 2022, the patient received Havrix. On 13th June 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional Information: GSK Receipt Date: 13-JUN-2022 Reporter's comments: The reporter was Health Care Professional from primary care clinic. The reporter stated that a patient was given a dose of Havrix. The reporter does not know if the dose was the patient's first or second dose in the series. The reporter did not had any patient information, aside from date of birth. At the time of reporting, the dose had not been repeated. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up. Additional Supportive Information: The reporter stated that a patient received an expired dose of Havrix which led to, expired vaccine used.
Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, chills alternating with sweats as well, fever continued for 2 days, also reporting swollen glands Narrative:  Symptoms persisted for 48 hours, with some lingering symptoms beyond 48 hours (headache, aches, swollen glands)
The pt developed redness, heat and tenderness the day after the shot on 12/13/01. The doctor gave cefadroxil 500mg BID.
pt recv vax 4APR96 & the next day pt devel an inj site rxn, characterized by pain, redness, & swelling;also exp fever & difficulty breathing;additional info was recv 31MAY96 & 10APR97 inj site redness was noted to extend to elbow;devel desq
Respiratory Reaction. Needed to use inhaler and flonase one hour after getting vaccine because of tightness in throat. Symptoms lasted approximately 3 hours. Patient has history of severe Asthma, along with mutiple allergies.
Medical Assistant gave Pfizer Covid-19 Vaccine 0.9 ml, instead of dosage of 0.3 ml
I had a rash that broke out on my face, severe fatigue, sore arms, major pelvic pain
- Redness/swelling at injection site, fever up to 103 degrees, vomiting and headache. - see attached sheet. Patient is 23-year-old female comes emergency department with complaint of fever for the last 3 days and she got the PNEUMOVAX shot. She states that she has redness, swelling of the left upper arm since she had the shot. She had fever to 103 maximum temperature at home. She complains of pain at the site of the vaccination. She is taking TYLENOL for her symptoms which does help with fever however when TYLENOL wears off fever comes back. She vomited 3 times but this was nonbloody and nonbilious. No diarrhea. No angioedema or shortness of breath. She complains of headache and congestion without rhinorrhea. She denies any ear pain or sore throat. No cough. Patient states she has difficulty raising her left arm overhead secondary to pain. Minimal shortness of breath.
2:30pm Widespread urticaria & throat fullness. BENADRYL 50mg given at 2:35pm. While going out to the car after vaccine he complained of stomach ache, throat fullness & general discomfort. He came right back in & was immediately evaluated.
FELT HORRIBLE; FATIGUE; HEAD HURTING/ HORRIBLE HEADACHE; FEELING FEVERISH; MOSTLY EXTREME STOMACH PAIN/STOMACH HURTING/ INTENSE PAIN LIKE SHE DRANK DAGGERS ALMOST; NAUSEA; This spontaneous case (PVX2019-1340) was received from a consumer on 24-May-2019. It describes a female consumer who experienced the adverse events "mostly extreme stomach pain/stomach hurting/ intense pain like she drank daggers almost/ incredible pain, nausea, felt horrible, insane pain, fatigue, head hurting/horrible headache, and feeling feverish", after the administration of oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer started experiencing extreme stomach pain and nausea, after taking a dose of Vivotif. She took the first dose of Vivotif on 21-May-2019 at 12 a.m. Then, on 22-May-2019, in the morning she ate small granola bar and a little bit of coffee, immediately she experienced, intense pain like she drank daggers. She stated that she woke up around 35 to 45 minutes before eating and she felt fine, but the moment she drank and ate, she experienced incredible pain. She reported that the adverse events were coming in waves and sometimes she felt horrible for four to five minutes and experienced head hurting, stomach hurting, nausea, and felt feverish. After the wave she again felt fine. She also experienced insane pain and fatigue, where she was not able to keep her eyes open. She stated that the fatigue she experienced was sleeping all day where she could not do anything, and she would "sit down and pass out." On 24-May-2019, when she woke up in the morning, she felt completely normal.   She took 2 dose of Advil (ibuprofen) for horrible headache.  She only took one dose of Vivotif and then discontinued it based on the nurse's recommendation.  She did not take any other vaccines or concomitant drugs along with Vivotif. She did not have any history of contaminated and unhygienic food or water intake.  Action taken with Vivotif was dosage discontinued.  The consumer had recovered from the reported events on 24-May-2019.  Company's Comment: In this case, it was reported that the consumer had experienced the adverse events "mostly extreme stomach pain/stomach hurting/ intense pain like she drank daggers almost/ incredible pain, nausea, felt horrible, insane pain, fatigue, head hurting/horrible headache, and feeling feverish", after the administration of oral Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. Hence, the causality of the events with Vivotif is assessed as possible.; Sender's Comments: Company's Comment: In this case, it was reported that the consumer had experienced the adverse events "mostly extreme stomach pain/stomach hurting/ intense pain like she drank daggers almost/ incredible pain, nausea, felt horrible, insane pain, fatigue, head hurting/horrible headache, and feeling feverish", after the administration of oral Vivotif. There seems to be a temporal association between the intake of the vaccine and the events. Hence, the causality of the events with Vivotif is assessed as possible.
48 hours after vaccine extreme pain.  Dr. Called treated with ice, Advil.  Hydrocodone Apap started 3/20/21.  Orthopedic surgeon on2/25/21, cortisone shot, X-rays....ice with a shoulder hardness.  No relief, extreme pain, not able to sleep more than a couple hours a night.  3/27/21family dr office, oxycodone acet makes me vomit, no relief.   2/28/21 dr office again, steroid shot in hip...relief for 24 hours.  Then pain returned.    3/1/21 another long acting steroid shot...no relief, still extreme pain!  3/3/21. Physical therapy.  3/4/21 dr office for steroid shot again...little relief, not long lasting!   3/5/21 Methylprednisolone, slept for 4 hours that night,     Eased some durning the day...no relief at night.     3/10/21.  MRI,  on shoulder.
2 weeks after receiving  vaccine had weakness, hunger and weight loss. Believed the vaccine triggered her hyperthyroidism to come back. Had to restart Methlmazole medication from her Endocrinologist.
Nauseous and light headed after receiving the vaccine. No food prior and had worked the night before.  she reported she was on blood pressure medicine but had not taken it yet.  First blood pressure was 223/120 02 saturation 100%.  Second blood pressure within 5 minutes was 213/121.  Third and final blood pressure was 198/122  . pulse 68 -70 beats.  Seen by Dr and released home.  Agreed to monitor her blood pressure at home, take her medicine and seek medical attention if needed.
Pneumovax given 6/29/05 and within 20 hours, developed fever and erythema of lateral arm, biceps area (injection to deltoid area). Resolved over several days with elevation and antibiotics. Suspect reaction to vaccine over cellulitis.
Approximately two days after the 2nd shot, I experienced chest pain and a chronic ache that felt localized to my heart. This isn't something I've experienced in the past. The chest pain/ache was accompanied by mild shortness of breath. Symptoms resolved approximately 5 days later.
Within days and weeks of the second injection I developed an overwhelming fatigue, stopped working out completely, at the same time suicidal thoughts ravaged my brain nonstop. I began to experience severe Anxiety and depression that I have not been able to overcome.   Bloodwork shows a drop in testosterone.  ECG showed Sinus bradycardia Possible Left atrial enlargement.  Prior to the vaccine I was working out with weights 3x/week and practicing yoga.  I had to call the suicide prevention line during a moment of clarity.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient reported vasovagal response during vaccine upon standing. Informed patient to stay seated after vaccine and not stand until feeling okay. Patient leanded head on counter, while I went to get water for patient fell and bumped head on ground.
Pt returned to Pharmacist about 45 minutes after vaccination stating she felt short of breath and wheezy . I took her back into the vaccination room. Pt took 25mg of Benadryl and drank some water and was observed for about 20 minutes at which poinst she stated she was feeling better and thought she was fine to go home, which was just down the street, where her mother that was a nurse was there as well
The following day of vaccination, patient felt lethargic. Two days after vaccination patient had headache, body aches, and chills. Three days after vaccination the patient complained of loss of hearing in the left ear and dizziness.
Surgery a few weeks ago and developed an allergic reaction to the adhesive used near her wounds; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Surgery a few weeks ago and developed an allergic reaction to the adhesive used near her wounds) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Surgery a few weeks ago and developed an allergic reaction to the adhesive used near her wounds). The patient was treated with PREDNISONE for Allergic reaction, at a dose of 4 milligram, taper dose-pack to be used over 6 days. At the time of the report, HYPERSENSITIVITY (Surgery a few weeks ago and developed an allergic reaction to the adhesive used near her wounds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter  Patient calling regarding concerns about receiving her second Moderna dose tomorrow (10Mar2021). Patient reports having surgery a few weeks ago and has developed an allergic reaction to the adhesive used near her wounds. Patient saw her surgeon and was prescribed a Prednisone  Patient is concerned the steroids will interfere with the efficacy of her second Moderna dose. Patient has consulted with her surgeon, a doctor, a PA, and her pharmacist to help her determine if she should delay her second dose for a week. Patient's surgeon reportedly encouraged her to take the dose-pack and receive her Moderna vaccine as scheduled. Patient reports her surgeon stated that the dose-pack is considered a "low dose" steroid.
on 12SEP98 about 30min p/vax pt exp increasing chest pain, SOB, arthralgia, body aching, chills & subjective fever x 3-4 days;